Effects of Different Anesthetic Gases on Hemodynamics, Arterial Oxygenation and Pulmonary Mechanics
Evaluation of the Effects of Different Anesthetic Gases on Hemodynamics, Arterial Oxygenation and Pulmonary Mechanics in Spinal Surgery.
1 other identifier
observational
50
1 country
1
Brief Summary
The bronchodilator effects of volatile anesthetics have been the subject of many clinical studies. It is known that all volatile anesthetics, especially halothane, have similar effects. Sevoflurane has been shown to reduce airway resistance more than halothane and isoflurane. Desflurane is difficult to use as an induction agent due to its harsh and extremely pungent odor and airway irritating effect. However, it has been shown that the risk of cough, respiratory arrest and laryngospasm is no different from sevoflurane when administered after intravenous induction. Although it irritates the airway, it is thought to have a bronchodilation effect as it stimulates the sympathetic system. In spinal surgeries, prone position is required to access the operating field. When the patient is placed in the prone position, pulmonary physiology are affected. In the prone position, V/Q mismatch decreases and arterial oxygenation increases. However, lung compliance decreases and the peak inspiratory pressure required to reach the required tidal volume increases. The main purpose of this study is the effect of volatile agents on lung mechanics and oxygenisation in the prone position.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 31, 2023
CompletedFirst Posted
Study publicly available on registry
November 7, 2023
CompletedStudy Start
First participant enrolled
December 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2024
CompletedJune 10, 2025
June 1, 2025
2 months
October 31, 2023
June 5, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
compliance
pulmonary compliance before, during and after prone position
2 hour
Study Arms (2)
sevoflurane
desflurane
Eligibility Criteria
ASA 1-2 patients between the ages of 18 and 65 who are scheduled for spinal surgery will be included in the study.
You may qualify if:
- years old
- ASA1-2
- Patients planned to undergo spinal surgery
You may not qualify if:
- Lung disease
- BMI 35 and above
- Smokers
- Those under the age of 18 and over the age of 65
- Hepatorenal disease
- Reynaud's disease
- Burger disease
- Hypotensive patient
- Neuromuscular disease
- Those who have had thoracic surgery before
- Those with bad Allen test results
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Yadigar Yılmaz
Istanbul, 34230, Turkey (Türkiye)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principal investigator
Study Record Dates
First Submitted
October 31, 2023
First Posted
November 7, 2023
Study Start
December 1, 2023
Primary Completion
February 1, 2024
Study Completion
February 1, 2024
Last Updated
June 10, 2025
Record last verified: 2025-06